Analyst stock forecast
MaxCyte Forecast: $4.11 Analyst Target
Direct answer
MaxCyte's average price target is $4.11.
The target implies +266.7% from the recorded current price, and the consensus rating is none.
The low target implies +117%, the high target implies +346.4%, and the range spans 229.5% of the current price.
Forecast evidence checked October 1, 2026.
Get free MaxCyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.12
- Average price target
- $4.11
- High price target
- $5.00
- Low price target
- $2.43
- Low target gap
- +117%
- Target upside
- +266.7%
- High target gap
- +346.4%
- Target range width
- 229.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- October 1, 2026
- Valid through
- October 8, 2026
Explore related company data
Read the frequently asked questions.
What is MaxCyte's average price target?
MaxCyte's verified average price target is $4.11. The target range is $2.43 to $5.00.
How far are MaxCyte's low and high targets from the recorded price?
The low target implies +117%, while the high target implies +346.4%.
How many analysts are included in MaxCyte's consensus?
The verified consensus includes 4 analysts.
How is MaxCyte's target upside or downside calculated?
The average target of $4.11 is divided by the recorded price of $1.12, then one is subtracted to produce +266.7%. This does not guarantee a future return.
When was MaxCyte's analyst forecast verified?
The data was verified on 2026-10-01. The dataset is valid through 2026-10-08.